Monday 23 April |
Foreign & Colonial Investment Trust |
Bioquell |
Microgen |
HgCapital Trust |
Silence Therapeutics |
Tuesday 24 April |
Shire |
Hammerson |
Metro Bank |
London Stock Exchange Group |
Tribal Group |
Alfa Financial Software Holdings |
UK Oil & Gas Investments |
Wednesday 25 April |
Drax Group |
British American Tobacco |
CLS Holdings |
Croda International |
Devro |
Mithras Investment Trust |
Nichols |
Personal Group Holdings |
Polar Capital Global Financials Trust |
Tullow Oil |
Countrywide |
EP Global Opportunities Trust |
Persimmon |
intu properties |
BlackRock World Mining Trust |
Polymetal International |
Thursday 26 April |
CRH |
Sthree |
Elementis |
Murray International Trust |
STV Group |
Admiral Group |
Fidessa Group |
French Connection Group |
Just Eat |
Aggreko |
Cobham |
FDM Group |
LSL Property Services |
Meggitt |
RIT Capital Partners |
Schroders |
SDL |
Synthomer |
Taylor Wimpey |
Weir Group |
Friday 27 April |
Rotork |
Ultra Electronics Holdings |
Travis Perkins |
Merlin Entertainments |
LMS Capital |
Laird |
Hutchison China Meditech |
Senior |
![ShareCast](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
Hutchmed strikes collaboration deal with Epizyme
(Sharecast News) - Commercial-stage biotechnology company Hutchmed China announced a collaboration to research, develop, manufacture and commercialise 'Tazverik' in Greater China on Monday, including mainland China, Hong Kong, Macau and Taiwan.
Read more